Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D011342:Procainamide